Tech Company Financing Transactions
Cerecor Funding Round
Private investors invested in a $6.8 million Series A capital raise for Cerecor. This venture round was announced on 9/16/2013.
Transaction Overview
Company Name
Announced On
9/16/2013
Transaction Type
Venture Equity
Amount
$6,800,000
Round
Series A
Investors
Proceeds Purpose
The proceeds from the transaction provide working capital to complete the acquisition and technology transfer of CERC-301, a selective NR2B antagonist candidate for the treatment of depression, and the COMT platform in-licensed from Merck.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
540 Gaither Rd. 400
Rockville, MD 20850
USA
Rockville, MD 20850
USA
Phone
Website
Email Address
Not Recorded
Overview
Cerecor Inc. is a clinical-stage biopharmaceutical company with the goal of becoming a leader in the development of innovative drugs that make a difference in the lives of patients with neurological and psychiatric disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Joseph Miller
Chief Scientific Officer
Perry Calias
VP - Bus. Development
James Harrell
Browse more venture capital transactions:
Prev: 9/16/2013: Vivex Biomedical venture capital transaction
Next: 9/16/2013: Layer venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs